127 related articles for article (PubMed ID: 18823)
1. The failure to demonstrate an involvement of human leukocyte group 5 antigens in graft-versus-host disease and marrow graft rejection.
Warren RP; Storb R; Nguyen DD; Thomas ED
Transplantation; 1977 Jul; 24(1):89-91. PubMed ID: 18823
[No Abstract] [Full Text] [Related]
2. [Host-graft interactions after allogenic bone marrow transplantation; choice of donor].
Alby N; Bernard A; Devergie A; Goldman JM; Hervé P; Maraninchi P; Raffoux C; Gluckman E
Nouv Rev Fr Hematol (1978); 1988; 30(1-2):55-64. PubMed ID: 3290840
[TBL] [Abstract][Full Text] [Related]
3. [The HLA complex. 3. Implications in transplantation and transfusion].
Dausset J
Nouv Presse Med; 1976 May; 5(22):1413-6. PubMed ID: 6945
[No Abstract] [Full Text] [Related]
4. Bone marrow transplantation from genetically HLA-nonidentical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: use of two monoclonal antibodies to prevent graft rejection.
Jabado N; Le Deist F; Cant A; De Graeff-Meeders ER; Fasth A; Morgan G; Vellodi A; Hale G; Bujan W; Thomas C; Cavazzana-Calvo M; Wijdenes J; Fischer A
Pediatrics; 1996 Sep; 98(3 Pt 1):420-8. PubMed ID: 8784367
[TBL] [Abstract][Full Text] [Related]
5. [Bone marrow graft: graft versus host reaction and rejection].
Fischer A; Griscelli C
Nephrologie; 1986; 7(3 Suppl):1-4. PubMed ID: 3534616
[TBL] [Abstract][Full Text] [Related]
6. Soluble H-2 antigens: effect on graft-versus-host reaction and factors influencing its effect on host-versus-skin-graft reaction.
Halle-Pannenko O; Martyre MC; Mathé G
Transplant Proc; 1972 Dec; 4(4):517-21. PubMed ID: 4405145
[No Abstract] [Full Text] [Related]
7. The influence of graft-versus-host reactivity, lymphocyte depletion, and cell dose on allogeneic bone marrow engraftment.
Glass B; Uharek L; Gaska T; Gassmann W; Löffler H; Müller-Ruchholtz W
Bone Marrow Transplant; 1993; 12 Suppl 3():S41-7. PubMed ID: 8124257
[TBL] [Abstract][Full Text] [Related]
8. HL-A and mixed leukocyte culture matched allogeneic bone marrow transplantation in patients with acute leukemia.
Graw RG; Leventhal BG; Yankee RA; Rogentine GN; Whang-Peng J; Ginnif MH; Herzig GP; Halterman RH; Henderson ES
Transplant Proc; 1971 Mar; 3(1):405-8. PubMed ID: 4106326
[No Abstract] [Full Text] [Related]
9. Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation.
Russell CA
Dan Med Bull; 2002 May; 49(2):89-108. PubMed ID: 12064093
[TBL] [Abstract][Full Text] [Related]
10. Failure of engraftment and graft-versus-host disease after canine marrow transplantation. Two phenomena linked to but not exclusively determined by known antigens of the major histocompatibility complex.
Storb R; Weiden PL; Graham TC; Thomas ED
Transplant Proc; 1978 Mar; 10(1):113-8. PubMed ID: 24904
[No Abstract] [Full Text] [Related]
11. Successful treatment of incipient graft rejection with donor leukocyte infusions, further proof of a graft versus host lymphohaemopoietic effect.
Díez-Martín JL; Gómez-Pineda A; Serrano D; Carrión R; Balsalobre P; Buño I
Bone Marrow Transplant; 2004 May; 33(10):1037-41. PubMed ID: 15064692
[TBL] [Abstract][Full Text] [Related]
12. Major and minor histocompatibility systems in man and their importance in bone marrow transplantation.
van Rood JJ; van Leeuwen A
Transplant Proc; 1976 Sep; 8(3):429-36. PubMed ID: 62433
[No Abstract] [Full Text] [Related]
13. Simultaneous protection against allograft rejection and graft-versus-host disease after total lymphoid irradiation: role of natural killer T cells.
Liu YP; Li Z; Nador RG; Strober S
Transplantation; 2008 Feb; 85(4):607-14. PubMed ID: 18347541
[TBL] [Abstract][Full Text] [Related]
14. Marrow grafts between canine littermates showing one-way nonstimulation in mixed leukocyte culture.
Storb R; Weiden PL; Schroeder ML; Graham TC
Transplant Proc; 1975 Dec; 7(4):459-60. PubMed ID: 824
[No Abstract] [Full Text] [Related]
15. Allogeneic bone marrow transplantation in aplastic anemia--report of 25 cases.
Gluckman E; Devergie A; Marty M; Bussel A; Rottemboúrg J; Dausset J; Bernard J
Transplant Proc; 1978 Mar; 10(1):141-5. PubMed ID: 345552
[TBL] [Abstract][Full Text] [Related]
16. Histocompatibility and marrow transplantation.
Hansen JA; Clift RA; Thomas ED; Buckner CD; Mickelson EM; Storb R
Transplant Proc; 1979 Dec; 11(4):1924-9. PubMed ID: 43613
[No Abstract] [Full Text] [Related]
17. Matching for donor--host compatibility for bone marrow transplantation.
Amos DB
Transplant Proc; 1976 Dec; 8(4):687-92. PubMed ID: 11597
[No Abstract] [Full Text] [Related]
18. The double barrier in bone marrow transplantation.
van Bekkum DW
Semin Hematol; 1974 Jul; 11(3):325-40. PubMed ID: 4151846
[No Abstract] [Full Text] [Related]
19. [Allogenic bone marrow grafts (author's transl)].
Gluckman E; Marty M; Boiron M
Pathol Biol (Paris); 1977 Feb; 25(2):113-7. PubMed ID: 322042
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of bone marrow aplasia by allogenic bone marrow grafts].
Gluckman E; Bussel A; Benbunan M; Broquet MA; Schaison G; Dausset J; Bernard J
Nouv Presse Med; 1975 Apr; 4(16):1177-82. PubMed ID: 240152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
